← All companies
Caris Life Sciences, Inc.
CAI - CIK 0002019410
Market cap$4.85 B
Rank#1404
SEC filings102
Caris Life Sciences, Inc. trades as CAI and has a market capitalization of $4.85 B, making it the #1404 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $812.03M, up 97.0% from the prior year and net income of -$68.09M. This page tracks Caris Life Sciences, Inc. through 102 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$812.03MFY 2025
Net income (latest FY)-$68.09MFY 2025
Operating cash flow (latest FY)$83.16MFY 2025
Total assets (latest FY)$1.13BFY 2025
Net margin-8.4%latest FY
Financial performance
Net profit margin expanded from -111.5% to -8.4% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $4.85 B
- Share price (derived)market cap / shares outstanding
- $17.16
- EPS (diluted)FY 2025
- $-3.22
- Shares outstandingas of 2026-05-05
- 0.28B
- Total equityas of 2026-03-31
- $593.49M
- Return on equity
- -11.5%
- Long-term debtas of 2026-03-31
- $381.07M
- Cash & equivalentsas of 2026-03-31
- $819.90M
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-12 |
Recent press releases
- Caris Life Sciences Reports First Quarter 2026 Financial Results2026-05-07
Revenue growth of 79% driven by strong performance in molecular profiling services
Similar companies
The largest companies sharing Caris Life Sciences, Inc.'s SEC industry classification (services-medical laboratories).
Frequently asked questions
What is Caris Life Sciences, Inc.'s market cap?
Caris Life Sciences, Inc. (CAI) has a market capitalization of $4.85 B as of 2026-06-10, ranking #1404 among US-listed companies.
How much revenue does Caris Life Sciences, Inc. make?
Caris Life Sciences, Inc. reported revenue of $812.03M for fiscal year 2025, an increase of 97.0% year over year.
Is Caris Life Sciences, Inc. profitable?
In its latest fiscal year Caris Life Sciences, Inc. reported a net loss of $68.09M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.